{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:20:03Z","timestamp":1789435203324,"version":"build-2803163510"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Veterinary pharmaceuticals must be safe and effective for treating and preventing diseases in animal sectors. Strict adherence to regulations at every stage of production, storage, and administration is necessary as the global sector grows in order to lower the possibility of adverse veterinary drug events. Strong pharmacovigilance regulatory systems are critical in monitoring and managing safety concerns related with veterinary pharmaceuticals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aimed to investigate the implementation of veterinary pharmacovigilance, collaborative initiatives, and reporting practices within the veterinary sector across East African countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A thorough search was performed using online platforms such as Google Scholar, PubMed, the Web of Sciences, and regulatory Web sites. The search strategies relied heavily on selecting relevant published findings related to veterinary pharmacovigilance status, veterinary adverse drug event reporting practice, and collaborative efforts in veterinary pharmaceutical sectors within the East African landscape. This article search approach confirmed the inclusion state of veterinary pharmacovigilance and associated collaborative initiatives in the region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In comparison to more developed regions, the review indicated that the veterinary pharmacovigilance system in East African countries was still in its early state. A strong legislative foundation and a large commitment from the veterinary profession are needed to establish a nationwide veterinary pharmacovigilance system. The review reveals a significant lack of consistency in the infrastructure of veterinary pharmacovigilance among the countries of East Africa. Tanzania, Kenya, and Ethiopia have some institutional processes for veterinary pharmaceutical safety, but they lack thorough documentation, which suggests that this systems still require improvement. The analysis emphasizes how inadequate the reporting systems are for adverse veterinary medication events in the majority of East African nations. Given the challenges East Africa faces, customized strategies are required to guarantee the safety and oversight of veterinary medications and improve veterinary pharmacovigilance. For systems to be more effective, veterinary pharmaceutical legal frameworks must be strengthened and stakeholder collaboration must be improved. Stakeholders include legislators, law enforcement, customs officials, regulatory organizations, scientists, pharmaceutical businesses, veterinarians, farmers, and the general public.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A multidisciplinary strategy is needed to solve current gaps in veterinary pharmacovigilance and improve overall veterinary drug safety in East Africa. It is feasible to create more reliable methods for tracking and guaranteeing the safety of veterinary medications by combining the efforts of numerous stakeholders, including as legislators, regulatory agencies, veterinary practitioners, and the general public.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2024.1430587","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:47:36Z","timestamp":1730454456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A narrative review of veterinary pharmacovigilance situations and prospects in East African countries"],"prefix":"10.3389","volume":"11","author":[{"given":"Yesuneh Tefera","family":"Mekasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sete","family":"Nigussie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abibo Wondie","family":"Mekonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassahun","family":"Berrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnakew","family":"Mulaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaku Getahun","family":"Feleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-017-1054-z","article-title":"National post-market surveillance assessment of veterinary medicines in Korea during the past decade","volume":"13","author":"Kang","year":"2017","journal-title":"BMC Vet Res"},{"key":"ref2","first-page":"1","article-title":"Legislation for veterinary drugs control","volume":"38","author":"Fingleton","year":"2004","journal-title":"FAO Legal Pap Online"},{"key":"ref3","volume-title":"Pharmacovigilance: ensuring the safe use of medicines","year":"2004"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2478\/pjvs-2013-0027","article-title":"The toxicity and adverse effects of selected drugs in animals\u2013overview","author":"Siroka","year":"2013","journal-title":"Pol J Vet Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12917-022-03329-x","article-title":"Post marketing surveillance of selected veterinary medicines in Tanzania mainland","volume":"18","author":"Fimbo","year":"2022","journal-title":"BMC Vet Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2042098611425695","article-title":"Specific features of medicines safety and pharmacovigilance in Africa","volume":"3","author":"Isah","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"ref7","volume-title":"Review of the policy, regulatory and administrative framework for delivery of livestock health products and services in Eastern and Southern Africa report","author":"Luseba","year":"2015"},{"key":"ref8","volume-title":"The importance of pharmacovigilance safety monitoring of medicinal products","year":"2002"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2042098619864853","DOI":"10.1177\/2042098619864853","article-title":"Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo","volume":"10","author":"Nzolo","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1796","DOI":"10.1002\/vetr.1796","article-title":"UK veterinary professionals\u2019 perceptions and experiences of adverse drug reaction reporting","volume":"191","author":"Davies","year":"2022","journal-title":"Vet Rec"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","article-title":"Factors affecting the development of adverse drug reactions","volume":"22","author":"Alomar","year":"2014","journal-title":"Saudi Pharm J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-019-2043-1","article-title":"Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon","volume":"15","author":"Mouiche","year":"2019","journal-title":"BMC Vet Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1024\/0036-7281.151.1.12","article-title":"Vigilance for veterinary medicinal products: declarations of suspected adverse reactions in the year 2007","volume":"151","author":"M\u00fcntener","year":"2009","journal-title":"Schweizer Archiv fur Tierheilkunde"},{"key":"ref14","first-page":"63","article-title":"Mortality associated with fenbendazole administration in pigeons (Columba livia)","volume":"45","author":"Gozalo","year":"2006","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00210-010-0543-4","article-title":"Levamisole-induced reduction in seizure threshold: a possible role of nicotinic acetylcholine receptor-mediated pathway","volume":"382","author":"Rehni","year":"2010","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"ref16","first-page":"379","article-title":"Antiparasitic agents","volume-title":"Handbook of veterinary pharmacology","author":"Hsu","year":"2008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/9781118675014.ch29","article-title":"Antimicrobial drug use in cattle","volume-title":"Antimicrobial therapy in veterinary medicine","author":"Apley","year":"2013"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1002\/9781444322958","volume-title":"Veterinary Pharmacovigilance: adverse reactions to veterinary medicinal products","author":"Woodward","year":"2009"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JRS-1996-9202","article-title":"Drug safety regulations and strategies of the German authority for medicinal products","volume":"9","author":"Beckmann","year":"1996","journal-title":"Int J Risk Saf Med"},{"key":"ref20","first-page":"97","article-title":"Toxicity of antibiotics for animals","volume":"12","author":"Aksenov","year":"1973","journal-title":"Veterinariia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/377669","article-title":"Cattle raiding, cultural survival, and adaptability of East African pastoralists","volume":"44","author":"Gray","year":"2003","journal-title":"Curr Anthropol"},{"key":"ref22","first-page":"84","article-title":"Pharmacovigilance: present status and future perspectives","volume":"8","author":"Sawarkar","year":"2019","journal-title":"Pharma Innov J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e000224","DOI":"10.1136\/vetreco-2017-000224","article-title":"Veterinary pharmacovigilance in Europe: a survey of veterinary practitioners","volume":"4","author":"De Briyne","year":"2017","journal-title":"Vet Rec Open"},{"key":"ref24","volume-title":"The importance of pharmacovigilance","year":"2002"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.9734\/CSJI\/2022\/v31i5822","article-title":"Scope of pharmacovigilance: comprehensive review","volume":"31","author":"Khalid Abbood","year":"2022","journal-title":"Chem Sci Int J"},{"key":"ref26","volume-title":"Pharmacovigilance of veterinary medicinal products: manegments of adverse event report. Guideline","year":"2007"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2885.2005.00645.x","article-title":"Veterinary pharmacovigilance. Part 1. The legal basis in the European Union","volume":"28","author":"Woodward","year":"2005","journal-title":"J Vet Pharmacol Ther"},{"key":"ref28","volume-title":"Countering the problem of falsified and substandard drugs","author":"Buckley","year":"2013"},{"key":"ref29","first-page":"20","article-title":"Global regulatory strategy for veterinary medicines","volume":"11","author":"John","year":"2014","journal-title":"Regul Rapp"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40290-017-0210-x","article-title":"Medicines regulation in Africa: current state and opportunities","volume":"31","author":"Ndomondo-Sigonda","year":"2017","journal-title":"Pharmaceut Med"},{"key":"ref31","volume-title":"Speculative markets: drug circuits and derivative life in","author":"Peterson","year":"2014"},{"key":"ref32","article-title":"Trente-cinq ans d\u2019anthropologie du m\u00e9dicament en Afrique: retour sur l\u2019\u00e9tude des march\u00e9s informels, des h\u00f4pitaux et des usages pharmaceutiques. Commentaire de l\u2019article de Sjaak Van der Geest","volume":"14","author":"Baxerres","year":"2017","journal-title":"Anthropologie Sant\u00e9 Revue internationale francophone d'anthropologie de la sant\u00e9"},{"key":"ref33","volume-title":"How to set up a pharmacovigilance system for veterinary medicinal products","year":"2022"},{"key":"ref34","volume-title":"Harmonisation of the registration and control of veterinary medicinal products in Africa. report","year":"2007"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"558973","DOI":"10.3389\/fvets.2021.558973","article-title":"Access to veterinary drugs in sub-saharan Africa: roadblocks and current solutions","volume":"8","author":"Jaime","year":"2022","journal-title":"Front Vet Sci"},{"key":"ref36","volume-title":"Document study on animal health auxiliaries: France-MAE","author":"Blanc","year":"2003"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4102\/jsava.v72i3.634","article-title":"Suspected adverse reactions to veterinary drugs reported in South Africa (January 1998-February 2001)","volume":"72","author":"Gehring","year":"2001","journal-title":"J S Afr Vet Assoc"},{"key":"ref38","volume-title":"Harmonisation of the registration and control of veterinary medicinal products in africa. Report","author":"Dare","year":"2007"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"6669036","DOI":"10.1155\/2021\/6669036","article-title":"Veterinary drug prescribing practices at selected district veterinary clinics of rift valley areas of Ethiopia","volume":"2021","author":"Etefa","year":"2021","journal-title":"Vet Med Int"},{"key":"ref40","volume-title":"Review of the policy, regulatory and administrative framework for delivery of livestock health products and services in Eastern and Southern Africa","author":"Luseba","year":"2015"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41182-023-00575-z","article-title":"Administration of ivermectin to cattle induced mortality, reduced fecundity and survivorship of Anopheles arabiensis in Ethiopia: an implication for expansion of vector control toolbox","volume":"52","author":"Damene","year":"2024","journal-title":"Trop Med Health"},{"key":"ref42","volume-title":"The veterinary pharmaceutical industry in Africa: a study of Kenya, Uganda and South Africa","author":"Grasswitz","year":"2004"},{"key":"ref43","volume-title":"Review of requirements and processes for registration of veterinary products in selected African and Asian countries","author":"Van Gool","year":"2015"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4314\/ejhs.v26i3.9","article-title":"Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation","volume":"26","author":"Suleman","year":"2016","journal-title":"Ethiop J Health Sci"},{"key":"ref45","volume-title":"Veterinary Medicines Updates Bulletin Issue 5, June 2020","year":""},{"key":"ref46","volume-title":"Veterinary Medicine Updates. Bulletin Issue. 6\/10\/2021","year":""},{"key":"ref47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.14-0535","article-title":"Monitoring the quality of medicines: results from Africa, Asia, and South America","volume":"92","author":"Hajjou","year":"2015","journal-title":"Am J Trop Med Hygiene"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e008564","DOI":"10.1136\/bmjgh-2022-008564","article-title":"The quality of veterinary medicines and their implications for One Health","volume":"7","author":"Vidhamaly","year":"2022","journal-title":"BMJ Glob Health"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1586\/17512433.2015.1053391","article-title":"Pharmacovigilance in resource-limited countries","volume":"8","author":"Olsson","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s40264-021-01102-x","article-title":"Eritrean pharmacovigilance system: key strategies, success stories, challenges and lessons learned","volume":"44","author":"Russom","year":"2021","journal-title":"Drug Saf"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40264-019-00898-z","article-title":"Comparative assessment of the national pharmacovigilance systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania","volume":"43","author":"Barry","year":"2020","journal-title":"Drug Saf"},{"key":"ref52","volume-title":"Comprehensive assessment of pharmacovigilance systems and their performance in Sub-Saharan Africa. 11th international conference of drug regulatory authorities presented China","author":"Choi","year":"2012"},{"key":"ref53","volume-title":"Safety of medicines in sub-Saharan Africa: assessment of pharmacovigilance systems and their performance","author":"Program","year":"2011"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40264-019-00807-4","article-title":"Pharmacovigilance systems in Arab countries: overview of 22 Arab countries","volume":"42","author":"Alshammari","year":"2019","journal-title":"Drug Saf"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1002\/9780470975053","volume-title":"Stephens\u2019 detection and evaluation of adverse drug reactions: principles and practice","author":"Talbot","year":"2011"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1430587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:32:49Z","timestamp":1731497569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1430587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":55,"alternative-id":["10.3389\/fvets.2024.1430587"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2024.1430587","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"1430587"}}